Form 4 for OPRX OptimizeRx Corp
Accepted 2021-09-09 00:00:00 ET · period of report 2021-09-07 · accession 0001213900-21-047223 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-09 | 2021-09-07+ | OPRX | BAKER DOUGLAS P | CFO | S - Sale+OE | $67.85 | -12.2K | 48.6K | -20% | -$829.9K |
| D | 2021-09-09 | 2021-09-08 | OPRX | BAKER DOUGLAS P | CFO | M - OptEx | $7.51 | +10.0K | 58.6K | +21% | +$75.1K |
| D | 2021-09-09 | 2021-09-08 | OPRX | BAKER DOUGLAS P | CFO | M - OptEx | $7.51 | -10.0K | 44.7K | -18% | -$75.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock (pursuant to 10B5-1 plan) | 2021-09-07 | S | D | 2,232 | $70.53 | 48,564 | D | — | — | (F2) These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |
| 2 | Common | Common Stock | 2021-09-08 | M | A | 10,000 | $7.51 | 58,564 | D | — | — | |
| 3 | Common | Common Stock (pursuant to 10B5-1 plan) | 2021-09-08 | S | D | 10,000 | $67.25 | 48,564 | D | — | — | (F1) These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |
| 4 | Derivative | Stock Option | 2021-09-08 | M | D | 10,000 | $7.51 | 44,699 | D | $7.51 · 2020-06-30 to 2022-03-31 | 10,000 Common Stock |